Position in ALXO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$150,375
New position
Shares Held
75,000
first reported quarter
Ownership
0.056%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#36
of 68 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026OMERS ADMINISTRATION Corp holds $60,860,531 across 83 Biotechnology names. ALXO ranks #47 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
18,797 | $8,393,612 | |
| 2 | TECH |
BIO-TECHNE Corp
|
141,443 | $7,391,811 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
8,179 | $6,319,422 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
73,789 | $4,768,983 | |
| 5 | INCY |
Incyte Corp
|
41,083 | $3,866,731 | |
| 6 | RPRX |
Royalty Pharma plc
|
79,307 | $3,804,356 | |
| 7 | EXEL |
Exelixis, Inc.
|
88,362 | $3,789,846 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
8,092 | $1,529,792 |
All Filings in ALXO
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $150,375 | 75,000 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||